{"id":"https://openalex.org/W4412408317","doi":"https://doi.org/10.1136/bmjoo-2025-bca.10","title":"OP-10 Eye disease secondary to eczema","display_name":"OP-10 Eye disease secondary to eczema","publication_year":2025,"publication_date":"2025-04-29","ids":{"openalex":"https://openalex.org/W4412408317","doi":"https://doi.org/10.1136/bmjoo-2025-bca.10"},"language":"en","primary_location":{"id":"doi:10.1136/bmjoo-2025-bca.10","doi":"https://doi.org/10.1136/bmjoo-2025-bca.10","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjoo-2025-bca.10","pdf_url":"https://bmjophth.bmj.com/content/10/Suppl_2/A3.3.full.pdf","source":null,"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the Bowman Club Meeting 2025","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmjophth.bmj.com/content/10/Suppl_2/A3.3.full.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113609998","display_name":"Seema Anand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799390153","display_name":"Leeds Teaching Hospitals NHS Trust","ror":"https://ror.org/00v4dac24","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Seema Anand","raw_affiliation_strings":["Leeds Teaching Hospitals NHS Trust, Leeds, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leeds Teaching Hospitals NHS Trust, Leeds, UK","institution_ids":["https://openalex.org/I2799390153"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5113609998"],"corresponding_institution_ids":["https://openalex.org/I2799390153"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A3.3","last_page":"A4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.9179999828338623,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.9179999828338623,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.05050000175833702,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11826","display_name":"Ocular Infections and Treatments","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ocular-surface-disease","display_name":"ocular surface disease","score":0.6610000133514404},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.6380000114440918},{"id":"https://openalex.org/keywords/blepharitis","display_name":"blepharitis","score":0.7720000147819519},{"id":"https://openalex.org/keywords/dry-eye-disease","display_name":"dry eye","score":0.7699999809265137},{"id":"https://openalex.org/keywords/scleritis","display_name":"scleritis","score":0.4779999852180481},{"id":"https://openalex.org/keywords/conjunctival-inflammation","display_name":"conjunctival inflammation","score":0.5490000247955322},{"id":"https://openalex.org/keywords/fungal-keratitis","display_name":"fungal keratitis","score":0.6970000267028809},{"id":"https://openalex.org/keywords/mycophenolate","display_name":"mycophenolate","score":0.6050000190734863},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.9399999976158142},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9509999752044678},{"id":"https://openalex.org/keywords/methylprednisolone","display_name":"methylprednisolone","score":0.7089999914169312},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.625}],"concepts":[{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.42183977365493774},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37883830070495605}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/bmjoo-2025-bca.10","doi":"https://doi.org/10.1136/bmjoo-2025-bca.10","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjoo-2025-bca.10","pdf_url":"https://bmjophth.bmj.com/content/10/Suppl_2/A3.3.full.pdf","source":null,"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the Bowman Club Meeting 2025","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/bmjoo-2025-bca.10","doi":"https://doi.org/10.1136/bmjoo-2025-bca.10","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjoo-2025-bca.10","pdf_url":"https://bmjophth.bmj.com/content/10/Suppl_2/A3.3.full.pdf","source":null,"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the Bowman Club Meeting 2025","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.4699999988079071,"display_name":"Zero hunger","id":"https://metadata.un.org/sdg/2"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4412408317.pdf","grobid_xml":"https://content.openalex.org/works/W4412408317.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4391375266","https://openalex.org/W2899084033","https://openalex.org/W2748952813","https://openalex.org/W3031052312","https://openalex.org/W4389568370","https://openalex.org/W3032375762","https://openalex.org/W1995515455","https://openalex.org/W2080531066","https://openalex.org/W3108674512","https://openalex.org/W1506200166"],"abstract_inverted_index":{"Case":[0],"40-year":[1],"female.":[2],"Referred":[3],"after":[4],"9":[5],"years":[6],"of":[7,119,141],"treatment":[8],"as":[9,131,143],"dry":[10],"eyes/blepharitis/allergic":[11],"eye":[12,41],"disease":[13],"secondary":[14],"to":[15,65,101,113],"eczema.":[16],"Very":[17],"mild":[18],"eczema":[19],"controlled":[20],"on":[21,43,124],"emollients,":[22],"no":[23],"significant":[24],"periocular":[25],"involvement.":[26],"Severe":[27],"bilateral":[28,51],"ocular":[29],"surface":[30],"inflammation":[31,90],"at":[32,138],"presentation-":[33],"severe":[34,86,111],"conjunctival":[35,55],"inflammation/limbitis/supero-temporal":[36],"inflammatory":[37],"nodule":[38],"in":[39,48],"right":[40],"encroaching":[42],"cornea,":[44],"inferior":[45],"forniceal":[46],"shortening":[47],"both":[49],"eyes,":[50],"dense":[52,145],"SPK.":[53],"Previous":[54],"biopsies":[56],"negative":[57],"for":[58],"pemphigoid/neoplasia.":[59],"Full":[60],"auto-immune":[61],"profile":[62],"negative.Initial":[63],"response":[64,112],"IV":[66,127],"Methyl":[67],"Pred":[68],"+":[69,98,126],"MMF":[70],"but":[71],"left":[72],"fungal":[73],"keratitis,":[74],"anaesthetic":[75],"abuse,":[76],"therapeutic":[77],"PK,":[78],"recurrence,":[79],"evisceration":[80],"within":[81],"6":[82],"weeks.Right":[83],"only":[84],"eye-":[85],"SPK":[87,146],"with":[88,110,147],"chronic":[89],"despite":[91,152],"mycophenolate":[92],"1.5":[93],"gms":[94],"BD,":[95],"oral":[96],"cyclosporine":[97],"never":[99],"managed":[100],"reduce":[102],"prednisolone":[103],"below":[104],"30":[105],"mgs.":[106],"Extreme":[107],"conj":[108],"hyperactivity":[109],"any":[114],"stimulus-":[115],"plugs/an":[116],"increasing":[117],"number":[118],"topical":[120],"drops/fluorescein.":[121],"Now":[122],"started":[123],"cyclophosphamide":[125],"methylprednisolone":[128],"vasculitis":[129],"regime":[130],"recent":[132],"acute":[133],"flare":[134],"up.":[135],"But":[136],"also":[137],"high":[139],"risk":[140],"infection":[142],"persistent":[144],"recurrent":[148],"small":[149],"epithelial":[150],"defects":[151],"autologous":[153],"serum/max":[154],"lubricants.":[155],"Also":[156],"patient":[157],"has":[158],"low":[159],"pain":[160],"tolerance":[161],"and":[162],"anxiety/depression":[163],"making":[164],"overall":[165],"management":[166],"challenging.":[167]},"counts_by_year":[],"updated_date":"2026-08-23T07:36:19.812096","created_date":"2025-10-10T00:00:00"}